Skip to content

LONA LONA Retained Earnings

Retained Earnings at other companies

Eli Lilly logo
Eli LillyLLY
$29.51B+95.5%
Arvinas logo
ArvinasARVN
-$1.67B-15.3%
Olema Pharmaceuticals, Inc. logo
Olema Pharmaceuticals, Inc.OLMA
-$650.65M-39.8%
Aura Biosciences, Inc. logo
Aura Biosciences, Inc.AURA
-$514.1M-28.0%
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
-$279.63M-87.1%
Erasca, Inc. logo
Erasca, Inc.ERAS
-$1.08B-34.7%

Other financials

Income statement

See full
Operating income-$17.2M-80.5%
Net income-$32.9M-260%
EPS (diluted)-$1.73+26.1%

Balance sheet

See full
Cash & equivalents$32.8M+24.3%
Total debt$691.0K-38.2%
Total equity$49.3M+32.1%
Total assets$71.6M+64.5%

Cash flow

See full
Operating cash flow-$20.9M-42.5%
CapEx$28.0K-15.2%
Free cash flow-$26.0M+1.1%

Valuation

See full
Market cap$86.33M+223%
Enterprise value$54.18M

Returns & leverage

See full
Return on equity-298.8%-726pp
Debt / equity0.0×
Current ratio10.4×+3.1×

Where this comes from

Reported directly by LONA in its filing.

Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.

The official record: LONA’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about LONA's retained earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LONA's retained earnings?
LONA (LONA) reported retained earnings of -$544.7M in Q1 2026.
How has LONA's retained earnings changed year-over-year?
LONA's retained earnings decreased by 31.2% year-over-year, from -$415.29M to -$544.7M.
What is the long-term trend for LONA's retained earnings?
Over 5 years (2020 to 2025), LONA's retained earnings has grown at a 65.6% compound annual growth rate (CAGR), from -$41.04M to -$511.76M.
What does retained earnings mean?
Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.